Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer

BACKGROUND: Hepatocellular carcinoma (HCC) is a major health problem worldwide with increasing incidence rates. As HCC traditionally occurs in chronically inflamed livers, this inflammation aids to drive oncogenesis and often renders these lesions to be immunogenic and therefore potential targets fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Zachary J., Heinrich, Bernd, Steinberg, Seth M., Yu, Su Jong, Greten, Tim F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697069/
https://www.ncbi.nlm.nih.gov/pubmed/29157287
http://dx.doi.org/10.1186/s40425-017-0298-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697069/
https://www.ncbi.nlm.nih.gov/pubmed/29157287
http://dx.doi.org/10.1186/s40425-017-0298-2

Ejemplares similares